Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: A population-based study

Lung Cancer

Volumn 55, Issue 3, 2007, Pages 255-262

  Cote, M L ^a   Wenzlaff, A S ^a   Bock, C H ^a   Land, S J ^a   Santer, S K ^a   Schwartz, D R ^a   Schwartz, A G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Caucasians; Cytochrome p 450 polymorphisms; Lung cancer; Smoking

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; EARLY CANCER; FAMILY HISTORY; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SEX; SMOKING;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AMINO ACIDS, BRANCHED-CHAIN; ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; POLYMORPHISM, GENETIC; SMOKING;

EID: 33847332204     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.11.002     Document Type: Article

References (38)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Spivack S.D., Fasco M.J., Walker V.E., and Kaminsky L.S. The molecular epidemiology of lung cancer. Crit Rev Toxicol 27 (1997) 319-365
3. Spivack S.D., Hurteau G.J., Reilly A.A., Aldous K.M., Ding X., and Kaminsky L.S. CYP1B1 expression in human lung. Drug Metab Dispos 29 (2001) 916-922
4. Willey J.C., Coy E.L., Frampton M.W., Torres A., Apostolakos M.J., Hoehn G., et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 17 (1997) 114-124
5. Schoket B., Papp G., Levay K., Mrackova G., Kadlubar F.F., and Vincze I. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res 482 (2001) 57-69
6. Wenzlaff A.S., Cote M.L., Bock C.H., Land S.J., Santer S.K., Schwartz D.R., et al. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 26 (2005) 2207-2212
7. Drakoulis N., Cascorbi I., Brockmoller J., Gross C.R., and Roots I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin Invest 72 (1994) 240-248
8. Taioli E., Gaspari L., Benhamou S., Boffetta P., Brockmoller J., Butkiewicz D., et al. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32 (2003) 60-63
9. Miller D.P., Liu G., De Vivo I., Lynch T.J., Wain J.C., Su L., et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res 62 (2002) 2819-2823
10. Larsen J.E., Colosimo M.L., Yang I.A., Bowman R., Zimmerman P.V., and Fong K.M. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes Control 16 (2005) 579-585
11. Nakachi K., Imai K., Hayashi S., and Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53 (1993) 2994-2999
12. Ishibe N., Wiencke J.K., Zuo Z.F., McMillan A., Spitz M., and Kelsey K.T. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiol Biomarkers Prev 6 (1997) 1075-1080
13. Taioli E., Crofts F., Trachman J., Bayo S., Toniolo P., and Garte S.J. Radical differences in CYP1A1 genotype and function. Toxicol Lett 77 (1995) 357-362
14. Crofts F., Cosma G.N., Currie D., Taioli E., Toniolo P., and Garte S.J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis 14 (1993) 1729-1731
15. Kelsey K.T., Wiencke J.K., and Spitz M.R. A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis 15 (1994) 1121-1124
16. London S.J., Daly A.K., Fairbrother K.S., Holmes C., Carpenter C.L., Navidi W.C., et al. Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res 55 (1995) 6035-6037
17. Taioli E., Ford J., Trachman J., Li Y., Demopoulos R., and Garte S. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19 (1998) 813-817
18. Le Marchand L., Guo C., Benhamou S., Bouchardy C., Cascorbi I., Clapper M.L., et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14 (2003) 339-346
19. Vineis P., Veglia F., Benhamou S., Butkiewicz D., Cascorbi I., Clapper M.L., et al. CYP1A1 T3801C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104 (2003) 650-657
20. Houlston R.S. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10 (2000) 105-114
21. Landi M.T., Bertazzi P.A., Shields P.G., Clark G., Lucier G.W., Garte S.J., et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4 (1994) 242-246
22. Cosma G., Crofts F., Taioli E., Toniolo P., and Garte S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 40 (1993) 309-316
23. Crofts F., Taioli E., Trachman J., Cosma G.N., Currie D., Toniolo P., et al. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15 (1994) 2961-2963
24. Kim J.H., Sherman M.E., Curriero F.C., Guengerich F.P., Strickland P.T., and Sutter T.R. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non- smokers, and ex-smokers. Toxicol Appl Pharmacol 199 (2004) 210-219
25. Dresler C.M., Fratelli C., Babb J., Everley L., Evans A.A., and Clapper M.L. Gender differences in genetic susceptibility for lung cancer. Lung Cancer 30 (2000) 153-160
26. Mollerup S., Berge G., Baera R., Skaug V., Hewer A., Phillips D.H., et al. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer (2006)
27. Shimada T., Watanabe J., Kawajiri K., Sutter T.R., Guengerich F.P., Gillam E.M., et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20 (1999) 1607-1613
28. Wu M.F., Wu W.J., Chang G.C., Chen C.Y., Hu S.W., Tsai W.T., et al. Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicol Lett 150 (2004) 211-219
29. Watanabe J., Shimada T., Gillam E.M., Ikuta T., Suemasu K., Higashi Y., et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10 (2000) 25-33
30. Sorensen M., Autrup H., Tjonneland A., Overvad K., and Raaschou-Nielsen O. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett 221 (2005) 185-190
31. Hanna I.H., Dawling S., Roodi N., Guengerich F.P., and Parl F.F. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60 (2000) 3440-3444
32. Schlesselman J. Case control studies: design, conduct, analysis, ed. Oxford University Press; 1982.
33. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10 (2001) 1239-1248
34. Basham V.M., Pharoah P.D., Healey C.S., Luben R.N., Day N.E., Easton D.F., et al. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis 22 (2001) 1797-1800
35. Cascorbi I., Brockmoller J., and Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 56 (1996) 4965-4969
36. Masson L.F., Sharp L., Cotton S.C., and Little J. Cytochrome P-450 1Al gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161 (2005) 901-915
37. Schwartz A.G., Prysak G.M., Murphy V., Lonardo F., Pass H., Schwartz J., et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 11 (2005) 7280-7287
38. Stabile L.P., Davis A.L., Gubish C.T., Hopkins T.M., Luketich J.D., Christie N., et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 62 (2002) 2141-2150